Schedule 13G ownership disclosure

FOAMIX PHARMACEUTICALS LTD

Security class unavailable · CUSIP: M46135105

Event date: 2019-08-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-222574
Form type
SC 13G
Filer
Delaware Street Capital Master Fund, L.P.
CIK
CIK 1648576
Filed
Aug 15, 2019
Reporting period
Aug 09, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub